177 related articles for article (PubMed ID: 10359099)
1. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice.
Dyson PJ; Elliott JI
Eur J Immunol; 1999 May; 29(5):1456-66. PubMed ID: 10359099
[TBL] [Abstract][Full Text] [Related]
2. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
[TBL] [Abstract][Full Text] [Related]
3. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
[TBL] [Abstract][Full Text] [Related]
4. Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.
Sheard MA; Sharrow SO; Takahama Y
Scand J Immunol; 2000 Dec; 52(6):550-4. PubMed ID: 11119259
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
6. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
[TBL] [Abstract][Full Text] [Related]
7. In vitro negative selection of viral superantigen-reactive thymocytes by thymic dendritic cells.
Ferrero I; Anjuère F; MacDonald HR; Ardavín C
Blood; 1997 Sep; 90(5):1943-51. PubMed ID: 9292528
[TBL] [Abstract][Full Text] [Related]
8. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
10. Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen.
Aude-Garcia C; Attinger A; Housset D; MacDonald HR; Acha-Orbea H; Marche PN; Jouvin-Marche E
Mol Immunol; 2000 Nov; 37(16):1005-12. PubMed ID: 11395139
[TBL] [Abstract][Full Text] [Related]
11. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
[TBL] [Abstract][Full Text] [Related]
12. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
Okamoto M; Kimura S; Katagiri M
Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
[TBL] [Abstract][Full Text] [Related]
13. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
[TBL] [Abstract][Full Text] [Related]
14. T cell repertoire and clonal deletion of Mtv superantigen-reactive T cells in mice lacking CD4 and CD8 molecules.
Penninger JM; Schilham MW; Timms E; Wallace VA; Mak TW
Eur J Immunol; 1995 Jul; 25(7):2115-8. PubMed ID: 7621886
[TBL] [Abstract][Full Text] [Related]
15. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
Maillard I; Xenarios I; Diggelmann H; Orbea HA
Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
[TBL] [Abstract][Full Text] [Related]
16. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of T and B lymphocyte activation in nonobese diabetic mice.
Chiu PP; Jevnikar AM; Danska JS
J Immunol; 2001 Dec; 167(12):7169-79. PubMed ID: 11739540
[TBL] [Abstract][Full Text] [Related]
18. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.
Krummenacher C; Diggelmann H; Acha-Orbea H
J Virol; 1996 May; 70(5):3026-31. PubMed ID: 8627779
[TBL] [Abstract][Full Text] [Related]
20. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
Penninger JM; Wallace VA; Timms E; Mak TW
Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
